View this email in your browser
Trusted evidence. Informed decisions. Better health.

Issue 10, Spring 2020

NEW REVIEW: Stopping antihypertensive medications in older people

Newly published priority review:
Withdrawal of antihypertensive drugs in older people 

This authors of this priority review were successful applicants to the Cochrane Review Support Program

Plain language conclusions:

  • It may be safe to stop antihypertensive medications in older people who are taking the medication for high blood pressure or primary prevention of heart disease. 
  • Older adults should not stop any of their medications without talking to a healthcare professional. 
  • Future studies should include older adults who are taking multiple other medications and/or living with frailty.

Our latest reviews

As of June 2020, The Cochrane Library contains 73 reviews and 40 protocols under Cochrane Hypertension and 35 additional titles have been registered by the group for authors intending to undertake systematic reviews.

Latest protocols [P], reviews [R] and updates [U]:

*This is the fifth in a series of reviews on lipid-lowering drugs, including Atorvastatin, Cerivastatin, Fluvastatin, and Rosuvastatin

#CochraneToronto postponed to 2022

Cochrane’s Governing Board have concluded that it is the most appropriate decision to postpone the 2020 Toronto Cochrane Colloquium in its entirety for 2020 and instead hold it in the Fall of 2022.

The 2022 Colloquium will be held 11-14 September at the Westin Harbour Castle in Toronto, Ontario. Following the Cochrane Colloquium will be the Guidelines International Network (GIN) Conference from 21-24 September, also postponed from 2020. 

Methods Speaker Series - Register now!
UBC Therapeutics Initiative Methods Speaker Series events are free of charge and feature expert speakers presenting a wide range of research methods topics, including meta-analysis, rapid reviews, patient engagement, open science, and predatory publishing.

Presentations are recorded and the video recordings are posted online.

A list of past and future research methods topics is available here

Next presentation:

Open Science: Transparency and reproducibility in the research life cycle
Registration +

Wednesday 29 July
12:00 Vancouver
15:00 New York
20:00 London
Questions about blood pressure?

What do you want to know about blood pressure?

#AskCochraneHTN using this super fast 60 second survey:

RevMan Web & RevMan 5.4

RevMan Web (online) is recommended for Cochrane intervention and flexible reviews. It is designed to integrate with other systematic review software and new features and updates are added regularly. 

We strongly encourage Cochrane Hypertension authors to use RevMan Web.

RevMan 5 (desktop) is available for other review formats (diagnostic, methodology, overviews). It can also be used alongside RevMan Web for intervention and flexible reviews as needed.  A final version of RevMan 5 (RevMan 5.4) is now available for download. Please download RevMan 5.4 now if you wish to continue to work on your Cochrane Reviews in desktop RevMan

Priority Reviews and a COVID-19 Title Registration

We currently have the following reviews on the Cochrane Priority Reviews list:

  • Blood pressure targets in adults with hypertension
  • Effect of alcohol on blood pressure
  • Home versus office blood pressure monitoring for hypertension
  • Pharmacotherapy for mild hypertension

We have now registered our first COVID-19 title and work on the protocol is underway:
  • Renin-angiotensin system inhibitors for treating COVID-19 in adults


This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Cochrane Hypertension · 2176 Health Sciences Mall · Vancouver, BC V6T 1Z3 · Canada